Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723696 | SCV000112238 | uncertain significance | not provided | 2014-10-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000251169 | SCV000309734 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000251169 | SCV000527357 | likely benign | not specified | 2017-06-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001518323 | SCV001726994 | benign | Familial aplasia of the vermis; Orofaciodigital syndrome I | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345393 | SCV002652747 | likely benign | Primary ciliary dyskinesia; Inborn genetic diseases | 2015-04-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000723696 | SCV004166538 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | OFD1: BP4, BP7, BS2 |